title: Olanzapine and haloperidol: potential for neutropenia?
authors.forename: Nasreen
authors.initials: N
authors.lastname: Abdullah
authors.forename: Liouda
authors.initials: L
authors.lastname: Voronovitch
authors.forename: Stephen
authors.initials: S
authors.lastname: Taylor
authors.forename: Steven
authors.initials: S
authors.lastname: Lippmann
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000139:chemically induced*; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D006220:Haloperidol; D000077152:Olanzapine